Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis

Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis

Objective Recovery time and treatment effect of oseltamivir in influenza-like illness (ILI) differs between patient groups. A point-of-care test to better predict ILI duration and identify patients who are most likely to benefit from oseltamivir treatment would aid prescribing decisions in primary c...

Full description

Bibliographic Details
Main Authors: Nicolay Jonassen Harbin, Karin Rystedt, Morten Lindbaek, Ruta Radzeviciene, Johan Westin, Ronny Gunnarsson, Christopher C. Butler, Alike W. van der Velden, Theo J. Verheij, Pär-Daniel Sundvall
Format: Article
Language:English
Published: Taylor & Francis Group 2021-10-01
Series:Scandinavian Journal of Primary Health Care
Subjects:
c-reactive protein
influenza-like illness
recovery time
antiviral treatment
respiratory tract infections
primary health care
Online Access:http://dx.doi.org/10.1080/02813432.2021.2006482

Internet

http://dx.doi.org/10.1080/02813432.2021.2006482

Similar Items